Home » Newsletters » BioWorld

BioWorld

March 1, 1999

View Archived Issues

Appointments & Advancements

Other News To Note

Medarex Loses MDX-210 Partner, Plans to Proceed to Phase III

SuperGen Files SNDA Seeking Additional Indications For Nipent

Alzheimers Disease Hits Brain Neurons Years Before Memory And Cognitive Losses Appear

Invitrogen Completes $52.5M Initial Public Offering

Changed BIO Meeting Format Boosts Smaller-Cap Companies